The aim of this Programme is to make molecular imaging economic and accessible to patients by developing new, fast and easy-to-use chemistry for synthesis of radiopharmaceuticals. These innovations led by a multidisciplinary team of biologists, chemists and physicists will empower emerging scanning technologies and new therapeutic radionuclides. Ultimately our research will impact on the management of patients with oncological, neurological and cardiovascular diseases.
We will deliver this via a number of key aims:
o Production of novel radiotracers with a range of half-lives for positron emission tomography (PET) imaging.
o Improve the imaging acquisition and data analysis to enable a number of biological processes to be evaluated in a single scan, and to obtain better resolution images.
o Disseminate advancements to the user community including clinicians, radiochemists and industrial partners, leading to clinical translation.
o Engage public and patients with the research of the programme and its clinical significance.
Our public engagement programme is led by Samantha Terry at King's, Samantha is an advocate for public engagement of biosciences research, having organised a number of events about radiation biology she was a recipient of the 2018 Outreach and Engagement Award from the Royal Society of Biology. Gill Reid at Southampton will also be guiding these activities, she has extensive experience leading chemistry outreach work and currently chairs the RSC Outreach Working Group. Our team is also supported by the Wellcome/EPSRC Centre for Medical Engineering's public engagement officers who offer training, resources, funding and opportunities to get involved in public engagement.
We are currently planning our programme of events, if you have ideas and would like to be involved please contact Samantha Terry at firstname.lastname@example.org or Bernice Akpinar at email@example.com.
Public engagement is one of our Programme’s key aims, benefiting our research by gaining new insights and ideas, enhancing our teaching and learning. All members will be strongly encouraged organise and take part in public engagement activities, supported by a dedicated PE committee.
Our overarching aim is to involve researchers with public engagement activities with specific aims to:
o Engage under-represented audiences that may not ordinarily attend science events.
o Actively involve the general public with radioactivity in medical research.
o Steer our research by engaging with patients.
o Work with school children to inspire and engage them with chemistry and chemistry in medicine.
We will tailor our activities to focus on certain public groups. By identifying interests within communities we can ensure that research and engagement activities are of the highest quality
In particular, we will target:
o Patients that have undergone or may have PET scanning, for diagnosis or disease monitoring. Since this group is directly affected by our research we hope to it will lead to better informed researchers.
o The general public (non-scientists); here we hope to inform about the science behind our research and how the technologies developed are used in medicine.
o Primary and secondary school-aged children to inform and inspire them about the science behind our research and introduce different STEM careers.